Adenovirus Vector-Derived VA-RNA-Mediated Innate Immune Responses

Machitani, Mitsuhiro; Yamaguchi, Tomoko; Shimizu, Kahori; Sakurai, Fuminori; Katayama, Kazufumi; Kawabata, Kenji; Mizuguchi, Hiroyuki
September 2011
Pharmaceutics;Sep2011, Vol. 3 Issue 3, p338
Academic Journal
The major limitation of the clinical use of replication-incompetent adenovirus (Ad) vectors is the interference by innate immune responses, including induction of inflammatory cytokines and interferons (IFN), following in vivo application of Ad vectors. Ad vector-induced production of inflammatory cytokines and IFNs also results in severe organ damage and efficient induction of acquired immune responses against Ad proteins and transgene products. Ad vector-induced innate immune responses are triggered by the recognition of Ad components by pattern recognition receptors (PRRs). In order to reduce the side effects by Ad vector-induced innate immune responses and to develop safer Ad vectors, it is crucial to clarify which PRRs and which Ad components are involved in Ad vector-induced innate immune responses. Our group previously demonstrated that myeloid differentiating factor 88 (MyD88) and toll-like receptor 9 (TLR9) play crucial roles in the Ad vector-induced inflammatory cytokine production in mouse bone marrow-derived dendritic cells. Furthermore, our group recently found that virus associated-RNAs (VA-RNAs), which are about 160 nucleotide-long non-coding small RNAs encoded in the Ad genome, are involved in IFN production through the IFN-β promoter stimulator-1 (IPS-1)-mediated signaling pathway following Ad vector transduction. The aim of this review is to highlight the Ad vector-induced innate immune responses following transduction, especially VA-RNA-mediated innate immune responses. Our findings on the mechanism of Ad vector-induced innate immune responses should make an important contribution to the development of safer Ad vectors, such as an Ad vector lacking expression of VA-RNAs.


Related Articles

  • Wild-type adenoviruses from groups A–F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent. Appledorn, D. M.; Kiang, A.; McBride, A.; Jiang, H.; Seregin, S.; Scott, J. M.; Stringer, R.; Kousa, Y.; Hoban, M.; Frank, M. M.; Amalfitano, A. // Gene Therapy;Jun2008, Vol. 15 Issue 12, p885 

    Alternative human and non-human Ad serotype vectors are currently studied for gene therapy and/or vaccine applications to capitalize upon their likely ability to avoid pre-existing immunity to HAd5. However, relatively little attention has been given to the nature and scope of innate immune...

  • Viral evasion of interferon stimulated genes. Short, John A.L. // Bioscience Horizons: The National Undergraduate Research Journal;Jun2009, Vol. 2 Issue 2, p212 

    Viruses and their hosts since the dawn of time have been battling for supremacy. In recent years, the ‘Interferon Gateway’ encompassing interferon-alpha and -beta (IFN-α/β) expression, signalling and antiviral responses, has been uncovered. IFN-α/β are cytokines that...

  • The role of type I interferons in TLR responses. Noppert, Susie J.; Fitzgerald, Katherine A.; Hertzog, Paul J. // Immunology & Cell Biology;Aug2007, Vol. 85 Issue 6, p446 

    Recent advances in unravelling the complexities of the signalling pathways that constitute innate immunity have highlighted type I interferon as a key component in the response to infection. Here we focus on the emerging field of pattern-recognition receptor signalling, specifically Toll-like...

  • Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Fenner, Jennifer E.; Starr, Robyn; Cornish, Ann L.; Jian-Guo Zhang; Metcalf, Donald; Schreiber, Robert D.; Sheehan, Kathleen; Hilton, Douglas J.; Alexander, Warren S.; Hertzog, Paul J. // Nature Immunology;Jan2006, Vol. 7 Issue 1, p33 

    Suppressor of cytokine signaling 1 (SOCS1) is a critical regulator of cytokine signaling and immune responses. SOCS1-deficient mice develop severe inflammatory disease, but are very resistant to viral infections. Using neutralizing antibody to type I interferon (IFN-α and IFN-β) and mice...

  • Learning from the Messengers: Innate Sensing of Viruses and Cytokine Regulation of Immunity--Clues for Treatments and Vaccines. Melchjorsen, Jesper // Viruses (1999-4915);Feb2013, Vol. 5 Issue 2, p470 

    Virus infections are a major global public health concern, and only via substantial knowledge of virus pathogenesis and antiviral immune responses can we develop and improve medical treatments, and preventive and therapeutic vaccines. Innate immunity and the shaping of efficient early immune...

  • Molecular basis of the inflammatory response to adenovirus vectors. Liu, Q; Muruve, D A // Gene Therapy;Jun2003, Vol. 10 Issue 11, p935 

    Adenovirus vectors are extensively studied in experimental and clinical models as agents for gene therapy. Recent generations of helper-dependent adenovirus vectors have the majority of viral genes removed and result in vectors with a large carrying capacity, reduced host adaptive immune...

  • CR1/2 is an important suppressor of Adenovirus-induced innate immune responses and is required for induction of neutralizing antibodies. Seregin, S. S.; Aldhamen, Y. A.; Appledorn, D. M.; Schuldt, N. J.; McBride, A. J.; Bujold, M.; Godbehere, S. S.; Amalfitano, A. // Gene Therapy;Oct2009, Vol. 16 Issue 10, p1245 

    Human complement receptors 1 and 2 are well described as important regulators of innate and adaptive immune responses, having pivotal roles in regulating complement activation (CR1) and B-cell maturation/survival. In contrast, the role of the murine homologs of CR1 and CR2 (mCR1/2) have been...

  • Virus Infection Recognition and Early Innate Responses to Non-Enveloped Viral Vectors. Shayakhmetov, Dmitry M. // Viruses (1999-4915);Jan2010, Vol. 2 Issue 1, p244 

    Numerous human genetic and acquired diseases could be corrected or ameliorated if viruses are harnessed to safely and effectively deliver therapeutic genes to diseased cells and tissues in vivo. Innate immune and inflammatory response represents one of the key stumbling blocks during the...

  • Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome. Delaloye, Julie; Roger, Thierry; Steiner-Tardivel, Quynh-Giao; Le Roy, Didier; Reymond, Marlies Knaup; Akira, Shizuo; Petrilli, Virginie; Gomez, Carmen E.; Perdiguero, Beatriz; Tschopp, Jürg; Pantaleo, Giuseppe; Esteban, Mariano; Calandra, Thierry // PLoS Pathogens;Jun2009, Vol. 5 Issue 6, p1 

    Modified vaccinia virus Ankara (MVA) is an attenuated double-stranded DNA poxvirus currently developed as a vaccine vector against HIV/AIDS. Profiling of the innate immune responses induced by MVA is essential for the design of vaccine vectors and for anticipating potential adverse interactions...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics